News

Prom Tanning in '90s Behind Current Spike in Melanoma

Publish date: August 30, 2011

 

EXPERT ANALYSIS FROM THE AMERICAN ACADEMY OF DERMATOLOGY'S SUMMER ACADEMY MEETING

Dr. Rigel said that he had no relevant disclosures.

Pages

Recommended Reading

Capecitabine May Protect Against Skin Cancers After Transplant
MDedge Hematology and Oncology
FDA Okay Expected Soon for Melanoma Drug Ipilimumab
MDedge Hematology and Oncology
FDA: Ipilimumab Approved for Metastatic Melanoma
MDedge Hematology and Oncology
Once Again, Results Mixed for SN Biopsy in Melanoma
MDedge Hematology and Oncology
FDA Approves Peginterferon Alfa-2b for Melanoma
MDedge Hematology and Oncology
Ipilimumab and Beyond: New Therapies Imminent in Melanoma
MDedge Hematology and Oncology
Paraneoplastic Autoimmune Multiorgan Syndrome Proves Rapidly Fatal
MDedge Hematology and Oncology
Vemurafenib Will Open Floodgates for Melanoma Genotyping
MDedge Hematology and Oncology